en

PRODUCT DETAIL

Bevimlar 15 mg filmom obalené tablety

Code 4106E
MA number 16/0170/23-S
Product Form: tbl flm 45x1x15 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: STADA Arzneimittel AG, Germany
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF01 Rivaroxaban
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 10.08.2023
Validity: 10.08.2028
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Bevimlar 15 mg_tbl flm_03_2024.pdf  
PIL: PIL_Bevimlar 15 mg_20 mg_tbl flm_03_2024.pdf  
Dokument: Príručka pre predpisujúceho lekára_rivaroxabán_V1.pdf  
Safety feature Yes
Data update: 14.08.2023
eu-flag.png sk-flag.png